Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Immune Boost May Protect Newborns from AIDS

October 4, 2010 7:46 am | News | Comments

Researchers at Oregon Health & Science University may have uncovered a new weapon for combating HIV as it is passed from mother to newborn child.

TOPICS:

Heart-Lung Machine to Advance Safety Testing

October 4, 2010 7:42 am | News | Comments

Harvard bioengineers have been awarded more than $3 million in funding from the National Institutes of Health and the U.S. Food and Drug Administration to develop a "Heart-Lung Micromachine" that will accelerate drug safety and efficacy testing.

TOPICS:

CureVac Announces Data from Cancer Vaccine Trial

October 4, 2010 7:27 am | News | Comments

CureVac GmbH announced first data from an open-label phase 1/2a clinical trial of its mRNA vaccine CV9103 in patients with hormone-refractory prostate cancer with rising PSA and existing metastasis in the vast majority of patients.

TOPICS:
Advertisement

South Africa to Market Mood-Elevating Plant

October 4, 2010 7:20 am | by Jenny Gross | News | Comments

For hundreds of years, indigenous South Africans have chewed a plant they say reduces stress, relieves hunger, sedates and elevates moods. Now they have a license to study and market it, and plan to sell it over-the-counter worldwide.

TOPICS:

Pre-Existing Condition Insurance Plan Off to Rocky Start

October 4, 2010 7:03 am | by Ricardo Alonzo-Zaldivar | News | Comments

It's a centerpiece of President Barack Obama's health care remake, a lifeline available right now to vulnerable people whose medical problems have made them uninsurable.

TOPICS:

Sanofi Launches Hostile Takeover of Genzyme

October 4, 2010 7:01 am | by Greg Keller | News | Comments

France's Sanofi-Aventis launched an $18.5 billion hostile takeover offer for Genzyme Corp., stepping up its effort to capture the U.S. biotech company's promising drugs for high cholesterol and lucrative treatments for rare genetic disorders.

TOPICS:

Site-specific, Sustained-release Nimodipine to Prevent Vasospasm

October 4, 2010 6:35 am | by R. Loch Macdonald, MD, PhD, Chief Scientific Officer Edge Therapeutics, Inc., Som-Ming Leung, PhD, Associate Director of Corporate Operations Edge Therapeutics, Inc. | Articles | Comments

Cerebral vasospasm is a common and potentially catastrophic delayed complication of subarachnoid hemorrhage (SAH). Subarachnoid hemorrhage is bleeding into the cerebral spinal fluid and usually is due to rupture of a brain aneurysm or to head trauma.

TOPICS:

Disease-modifying Therapies for Parkinson’s and Alzhiemer’s

October 4, 2010 6:08 am | by Roche, Basel, Switzerland | Articles | Comments

According to the latest statistics from the WHO, there are currently around 35 million people diagnosed with Alzheimer’s disease. Additionally, Parkinson’s disease, the most common motor disorder, affects about 0.1% to 0.2% of the western population.

TOPICS:
Advertisement

Chemotaxis Assay Plate

October 1, 2010 8:15 am | Product Releases | Comments

TTP LabTech has announced a high throughput solution for chemotaxis research using the Acumen eX3 microplate cytometer and the iuvo Chemotaxis Assay Plate from BellBrook Labs.

TOPICS:

Cryopreserved Cells

October 1, 2010 8:04 am | Product Releases | Comments

Lonza now offers a broad selection of cryopreserved primary human diseased airway cells including, bronchial epithelial and smooth muscle cells, and lung fibroblasts from both chronic obstructive pulmonary disease, and asthmatic donors.

TOPICS:

Cardialysis And Sticares Collaborating on Development

October 1, 2010 7:17 am | News | Comments

Cardialysis and Sticares InterACT announced that they have entered into a strategic collaboration to provide drug development consulting services in the field of cardiovascular and metabolic medicine.

TOPICS:

AIKO Appoints New CEO

October 1, 2010 7:12 am | News | Comments

AIKO Biotechnology announced the appointment of industry veteran Jim New, Ph.D., to the newly created position of chief executive officer.

TOPICS:

Dyax Commercializing Ecallantide in Japan

October 1, 2010 7:09 am | News | Comments

Dyax Corp. and CMIC Co., Ltd, announced an agreement to develop and commercialize subcutaneous DX-88 (ecallantide) for the treatment of hereditary angioedema and other angioedema indications in Japan.

TOPICS:

Avila Begins Phase 1 Trial for Btk Drug

October 1, 2010 7:05 am | News | Comments

Avila Therapeutics, Inc. announced that it has initiated a phase 1 clinical trial to assess the safety, tolerability and pharmacokinetic profile of AVL-292, a novel, orally available, covalent drug that targets Bruton’s tyrosine kinase.

TOPICS:

New Gene Enables Sexual Maturity

October 1, 2010 6:54 am | News | Comments

A break in the two chromosomes has given scientists a break in finding a new gene involved in puberty, Medical College of Georgia researchers report.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading